Table of Contents
What “Stop Waiting for Permission to Heal” Actually Means
You need to stop waiting for permission to heal, and most people don’t realize they’ve been doing it.
The permission structure of modern medicine is so deeply embedded that most people don’t even notice it. You feel something. You wait for a doctor to confirm it matters. The doctor runs the standard panel. Nothing flagged. You’re told you’re fine. And you keep feeling the way you felt. That cycle — feel, wait, defer, repeat — is not healthcare. It’s managed uncertainty with a co-pay attached.
Two stories broke this week that put a number and a name on exactly how much that waiting has cost people. One involves veterans crossing international borders to access ibogaine therapy because their own government said not yet. The other involves a startup rescuing drugs that big pharma abandoned — not because the drugs didn’t work, but because the economics of running a trial didn’t pencil out at the time. In both cases the treatment existed. The patient existed. The gap between them was institutional permission, and nothing else.
This is what it costs to keep waiting.
The Psychedelic Turning Point: What Veterans Proved Before the Scientists Did
President Trump signed an executive order directing the FDA to fast-track clinical trials for psilocybin, ibogaine, and other psychedelic compounds. The order came with $50 million specifically for ibogaine research and a commitment to reschedule any drugs the FDA approves. Navy SEALs stood in the Oval Office. Veterans who had traveled to Mexico for treatment stood there too.
That’s not a photo opportunity. That’s a confession.
The federal government just admitted, implicitly, that the policy environment had failed a population of people badly enough that they started self-organizing workarounds across international borders. Veterans didn’t wait for the research to catch up. They talked to each other. They found clinics in Mexico. They got better. And they came back and told everyone.
Ibogaine is derived from the iboga plant, used for centuries in West African spiritual and healing traditions. What the clinical research shows is that it doesn’t suppress symptoms. It resets the brain’s own neurological signaling. For veterans with PTSD and addiction, a single session has produced results that years of pharmaceutical intervention couldn’t touch. The brain does the actual rewiring. The compound opens the window.
Critics say the evidence base isn’t strong enough yet. That’s a fair scientific argument. It’s also an argument that’s been running for twenty years while the veteran suicide rate stayed where it was. At some point, insisting on more evidence before acting becomes its own ethical position. And not a defensible one.
What this executive order represents, underneath the politics, is the policy finally following the patient. That almost never happens. When it does, it matters.
The Billion-Dollar Graveyard: Drugs That Worked and Got Buried Anyway
Formation Bio is an AI company valued at $1.8 billion that makes its money buying drugs big pharma gave up on. Not drugs that failed. Drugs that got abandoned because the clinical trial process was too slow and too expensive to justify the projected return.
Their founding argument is direct: drug discovery was never the bottleneck. Clinical development was. There was a nearly twofold increase in drug candidates over the past decade. The number of FDA approvals per year barely moved. The drugs existed. The pipeline didn’t.
Formation Bio’s AI can run clinical trials up to 50% faster by cutting administrative time, improving patient matching, and surfacing signals that human reviewers miss or dismiss. They’ve already licensed one drug to Sanofi for $630 million. Their knee osteoarthritis candidate — currently in late-stage trials — was nearly abandoned. A top drug evaluator on their team said he would have walked away from it without the AI analysis. The AI found the signal. The drug stayed in the game.
People are walking around in chronic knee pain right now who didn’t have to be. That drug was sitting in a drawer. Not because the science was wrong. Because someone ran the economics and decided not to continue.
Formation Bio is essentially a recovery operation for medicine that got left behind. And what they’re proving, one trial at a time, is that “we couldn’t afford to study it” is not the same as “it doesn’t work.” The graveyard is full of things that work.
Stop Waiting for Permission to Heal — 5 Ways to Start Now
You don’t need an executive order or a billion-dollar company to apply what both of these stories are really saying. Here are five direct moves:
The Spiritual Layer Most Medicine Ignores
Both stories this week are about what happens when you trust something the system hasn’t signed off on yet. That’s not a medical observation. That’s a spiritual one.
The veterans who booked flights to Mexico weren’t operating on data. They were operating on faith — in their own bodies, in each other, in the reports of people who’d been where they were and came back different. That trust preceded the evidence. And the evidence followed.
This is not unusual in the history of healing. Every tradition that has survived across centuries — and David has studied many of them, from TCM to Ayurveda to contemplative Christianity — starts from the same premise: the body carries intelligence that precedes diagnosis. The healer’s job is to create conditions for that intelligence to do its work.
Prayer and stillness aren’t separate from health practice. They are health practice. The patients who get the most out of every therapy — biological, pharmaceutical, or otherwise — are the ones who are paying attention inward. They feel the shift before the scan confirms it. They notice the signal early. Attentiveness is a clinical variable. Most systems just don’t have a billing code for it.
What Cellular Therapy Has in Common with Both Stories
At Regenerative Research Group, when stem cells or exosomes are introduced into tissue, the goal isn’t replacement. It’s signaling. The biologics don’t do the healing. They send information into a system that already knows how to heal, and they amplify the conversation that system is already trying to have.
That’s the same mechanism ibogaine operates on. The brain doesn’t need to be fixed. It needs a window. Open the window, get out of the way, and watch what the brain does with the space.
And it’s the same logic Formation Bio is applying. The drugs they’re rescuing aren’t being reimagined. They’re being given a second chance to reach patients whose biology was already prepared to respond. The AI isn’t inventing new medicine. It’s removing the bureaucratic friction standing between an existing treatment and the person it was built to help.
Stop waiting for permission to heal. The body has been ready. The treatments have often existed. What’s been missing is the institutional clarity to stop saying not yet.
EF-AQs
Is ibogaine therapy legal in the United States? As of April 2026, ibogaine remains a Schedule I controlled substance in the US, though President Trump’s executive order directs the FDA to fast-track clinical trials and reschedule any approved drugs. Many Americans have traveled to Mexico and other countries for legal ibogaine therapy. Read more →
What does it mean to stop waiting for permission to heal? It means taking ownership of your health before the system catches up to what your body is already telling you. It includes asking for screenings that aren’t standard, researching therapies in clinical development, and paying attention to signals your body is sending before they become a diagnosis. Read more →
How does AI improve clinical drug trials? Companies like Formation Bio use AI to match drug candidates to the right patient populations, cut administrative overhead, and surface data signals that human reviewers miss — reducing trial timelines by up to 50%. This means drugs that were economically abandoned can be re-evaluated and brought to patients faster. Read more →
What is cellular signaling and why does it matter for healing? Cellular signaling is the communication system your body uses to coordinate repair, immune response, and tissue regeneration. Therapies like stem cells and exosomes work by sending signals into this system — not replacing what’s there, but amplifying what the body is already trying to do. Read more →
Action Step
Ask the Question the System Hasn’t
Want the full breakdown? Read the newsletter →
📩 Get David’s weekly insights on longevity, peak performance, and body-mind-spirit alignment. Subscribe to Base Lift on Substack
